Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure

Published:2007-05-02 Issue:17 Volume:297 Page:1883
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Mebazaa Alexandre,Nieminen Markku S.,Packer Milton,Cohen-Solal Alain,Kleber Franz X.,Pocock Stuart J.,Thakkar Roopal,Padley Robert J.,Põder Pentti,Kivikko Matti,SURVIVE Investigators for the

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 830 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The DanGer Shock trial: a new dawn but much to uncover;European Heart Journal;2024-08-12

2. Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort;Archives of Cardiovascular Diseases;2024-08

3. Dobutamine in the Management of Advanced Heart Failure;Journal of Clinical Medicine;2024-06-27

4. ICU management of cardiogenic shock before mechanical support;Current Opinion in Critical Care;2024-06-13

5. Safety and efficacy of levosimendan in patients with cardiac amyloidosis;International Journal of Cardiology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP